The news: Deceptive health product ads targeting EU consumers are flooding ad platforms like  Facebook, according to a recent investigative report from Reset Tech.

By combing through Meta’s ad library and Google’s platforms, researchers identified over 350,000 Facebook ads and 2,073 Google ads launched between 2023 and 2026 that used unfounded medical claims to promote 390 different health supplements.

Digging into the details: The ads flagged in the report promoted unregulated and potentially dangerous nutraceuticals, sometimes impersonating doctors or celebrities and misusing pharma and organizational logos.

• Some misleading ad claims suggested products can cure chronic conditions like diabetes or psoriasis, or treat serious, potentially life-threatening issues such as arrhythmia or high blood pressure.
• Pfizer and Bayer brand logos appeared on multiple scam ads, though the products were unrelated to either company.
• Other ads impersonated established health institutions, such as the European Medicines Agency.

Why it matters: The content of the documented ads violates Meta's advertising policies. A Meta spokesman told the New York Times that the platform prohibits misleading ads that claim to cure incurable diseases, or that promote unsafe products and supplements.

Many of the ads remain on Facebook—and even those that have been removed haven’t fully resolved the problem, the report revealed. 

• About one-third of the 350,000+ ads on Facebook were not deleted by the time the report was published. 
• Even when individual scam ads are removed, networks of similar accounts could quickly generate new ones to replace them.
• For its part, Meta said it took down ads that violated its policies, per the NYT.

Even a limited number of consumers clicking ads and purchasing untested or potentially dangerous health products could meaningfully impact consumer health. The ads reached over 880 million EU users, though there was certainly overlap among different campaigns, the report found. Some vulnerable groups, such as older consumers, may have been disproportionately targeted.

Implications for healthcare marketers and ad platforms: Consumers who are interested in health products but vulnerable to scam ads need clearer guidance. 

Credible health and wellness brands should step in by educating folks on common red flags: “miracle cure” claims, fake urgency, misuse of logos, high-pressure purchasing tactics, and fabricated or AI-generated testimonials. This content should be distributed through accessible channels like newsletters, social media (including videos featuring medical professionals), and even digital health tools such as patient portals.

For ad platforms, scam ads with dubious claims aren’t just a Facebook problem—though the company is currently under US scrutiny for weak enforcement of misleading weight loss drug promotions. Ad platforms earn revenue from all ads—including low-quality or deceptive ones—but they also face strong incentives to enforce policies to protect user trust, maintain advertiser relationships, and avoid regulatory scrutiny. This is particularly critical in health advertising, where misleading ads can lead to harmful real-world decisions.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.